TransCode Therapeutics
(NASDAQ:RNAZ)
$1.25
-0.04[-3.10%]
Last update: 1:14PM
15 minutes delayed
Day High/Low1.18 - 1.27
52 Week High/Low1.15 - 7
Open / Close1.25 / -
Float / Outstanding8.8M / 13M
Vol / Avg.24.9K / 40.4K
Mkt Cap16.2M
P/E-
50d Avg. Price2.03
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float8.8M

TransCode Therapeutics (NASDAQ:RNAZ), Quotes and News Summary

TransCode Therapeutics (NASDAQ: RNAZ)

Day High/Low1.18 - 1.27
52 Week High/Low1.15 - 7
Open / Close1.25 / -
Float / Outstanding8.8M / 13M
Vol / Avg.24.9K / 40.4K
Mkt Cap16.2M
P/E-
50d Avg. Price2.03
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float8.8M
load more
Sector: Health Care.Industry: Biotechnology
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-22
REV
Q1 2022Est.ActualSurprise
EPS-0.270
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

TransCode Therapeutics Questions & Answers

Q
How do I buy TransCode Therapeutics (RNAZ) stock?
A

You can purchase shares of TransCode Therapeutics (NASDAQ: RNAZ) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are TransCode Therapeutics's (RNAZ) competitors?
Q
What is the target price for TransCode Therapeutics (RNAZ) stock?
A

The latest price target for TransCode Therapeutics (NASDAQ: RNAZ) was reported by HC Wainwright & Co. on Tuesday, June 7, 2022. The analyst firm set a price target for 10.00 expecting RNAZ to rise to within 12 months (a possible 700.00% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for TransCode Therapeutics (RNAZ)?
A

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $1.25 last updated Today at June 30, 2022, 5:14 PM UTC.

Q
Does TransCode Therapeutics (RNAZ) pay a dividend?
A

There are no upcoming dividends for TransCode Therapeutics.

Q
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
A

TransCode Therapeutics’s Q2 earnings are confirmed for Monday, August 22, 2022.

Q
Is TransCode Therapeutics (RNAZ) going to split?
A

There is no upcoming split for TransCode Therapeutics.

Q
What sector and industry does TransCode Therapeutics (RNAZ) operate in?
A

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.